Understanding Key Drivers and Growth Opportunities in the Pulmonary Drug Delivery Devices Market: Trends and Market Size Insights
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Primary Drivers Are Supporting the Continued Market Growth of thePulmonary Drug Delivery Devices Market?
The escalating prevalence of respiratory disorders is expected to drive the growth of the pulmonary drug delivery devices market. Respiratory disorders, driven by factors like air pollution and smoking, are on the rise. Pulmonary drug delivery devices are crucial for treating these conditions by directly delivering medication to the lungs. For instance, the CDC reported in May 2024 that the prevalence of asthma among adults increased from 8.0% in 2021 to 8.7% in 2022, supporting the growth of the pulmonary drug delivery devices market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15907&type=smp
How Has the Pulmonary Drug Delivery Devices Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?
The pulmonary drug delivery devices market size is projected to rise from $49.52 billion in 2024 to $53.21 billion in 2025, with a CAGR of 7.4%. The historic growth was due to the increasing prevalence of respiratory diseases like COPD, asthma, and cystic fibrosis, the growing aging population, rising awareness about respiratory health, expanded healthcare expenditure in emerging economies, and the adoption of homecare settings for respiratory therapy.
The pulmonary drug delivery devices market is expected to reach $69.91 billion by 2029 at a CAGR of 7.1%. This growth is attributed to the demand for personalized respiratory care, expansion of home healthcare and remote monitoring, increased R&D investment, and focus on preventive healthcare. Trends include technological innovations, a shift toward value-based care, telehealth integration in respiratory therapy, wearables for self-management, and the use of 3D printing and digital manufacturing.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15907
How Are Consumer Market Innovations Shaping the Current and Future Landscape of thePulmonary Drug Delivery Devices Market?
Companies in the pulmonary drug delivery devices market are advancing products such as small-volume nebulizers to improve patient care. In May 2024, Medline Industries LP, a US-based healthcare company, introduced the Hudson RCI TurboMist small-volume nebulizer. This device delivers medication faster than standard nebulizers, reducing treatment times by 70% and optimizing patient throughput.
Who Are the Key Market Players Influencing the Growth of the Corn and Pulmonary Drug Delivery Devices Industry?
Major companies operating in the pulmonary drug delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson and Company, Koninklijke Philips N.V., Medline Industries Inc., ResMed Inc., Drägerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Masimo Corporation, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc., Precision Medical Inc., Salter Labs Inc., Nidek Medical Products Inc.
Order Your Report Now For A Swift Delivery:
Which Key Market Segments Comprise the Pulmonary Drug Delivery Devices Market and Drive Its Revenue Growth?
The pulmonary drug delivery devices market covered in this report is segmented –
1) By Product Type: Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers
2) By Application: Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disease, Other Applications
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, E-Commerce
Subsegments:
1) By Dry Powder Inhalers (DPIs): Single-Dose DPIs, Multi-Dose DPIs
2) By Metered Dose Inhalers (MDIs): CFC-Based MDIs, HFA-Based MDIs
3) By Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=15907&type=smp
Which Regions Are Emerging as Leaders in the Pulmonary Drug Delivery Devices Market?
North America was the largest region in the pulmonary drug delivery devices market in 2023. The regions covered in the pulmonary drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Reports Similar to the Global Pulmonary Drug Delivery Devices Market 2025, By The Business Research Company:
Chronic Obstructive Pulmonary Disease (COPD) Treatment Global Market Report 2024
Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Advanced Drug Delivery Systems Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
